What question did this study set out to answer?

To address the diagnostic challenges and treatment options for pediatric gastrointestinal basidiobolomycosis.

February 6, 2026Open Access

Liposomal amphotericin B in the treatment of pediatric gastrointestinal basidiobolomycosis

MFMehdi ForooghiShiraz University of Medical Sciences SHSeyedeh Sedigheh HamzaviShiraz University of Medical Sciences SYShayan YousufzaiShiraz University of Medical Sciences

Key Points

To address the diagnostic challenges and treatment options for pediatric gastrointestinal basidiobolomycosis.
Case analysis of a pediatric patient with gastrointestinal basidiobolomycosis
Treatment with liposomal amphotericin B followed by itraconazole
Discussion on challenges in diagnosis and treatment standards
Successful management of the patient's condition with liposomal amphotericin B
Emphasis on the need for standardized treatment protocols
Support for further studies to optimize antifungal and surgical strategies

Abstract

This case highlights the diagnostic challenges of pediatric gastrointestinal basidiobolomycosis and demonstrates successful management with liposomal amphotericin B followed by itraconazole. It underscores the ongoing gap in establishing standardized treatment and supports further prospective studies to define optimal antifungal and surgical strategies for this rare entity.

KI fragen

Bookmark

View Full Paper